Electrostatic sheathing of lipoprotein lipase is essential for its movement across capillary endothelial cells
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Electrostatic sheathing of lipoprotein lipase is essential for its movement across capillary endothelial cells. / Song, Wenxin; Beigneux, Anne P.; Winther, Anne Marie L.; Kristensen, Kristian K.; Grønnemose, Anne L.; Yang, Ye; Tu, Yiping; Munguia, Priscilla; Morales, Jazmin; Jung, Hyesoo; De Jong, Pieter J.; Jung, Cris J.; Miyashita, Kazuya; Kimura, Takao; Nakajima, Katsuyuki; Murakami, Masami; Birrane, Gabriel; Jiang, Haibo; Tontonoz, Peter; Ploug, Michael; Fong, Loren G.; Young, Stephen G.
In: Journal of Clinical Investigation, Vol. 132, No. 5, e157500, 2022.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Electrostatic sheathing of lipoprotein lipase is essential for its movement across capillary endothelial cells
AU - Song, Wenxin
AU - Beigneux, Anne P.
AU - Winther, Anne Marie L.
AU - Kristensen, Kristian K.
AU - Grønnemose, Anne L.
AU - Yang, Ye
AU - Tu, Yiping
AU - Munguia, Priscilla
AU - Morales, Jazmin
AU - Jung, Hyesoo
AU - De Jong, Pieter J.
AU - Jung, Cris J.
AU - Miyashita, Kazuya
AU - Kimura, Takao
AU - Nakajima, Katsuyuki
AU - Murakami, Masami
AU - Birrane, Gabriel
AU - Jiang, Haibo
AU - Tontonoz, Peter
AU - Ploug, Michael
AU - Fong, Loren G.
AU - Young, Stephen G.
N1 - Publisher Copyright: © 2022 American Society for Clinical Investigation. All rights reserved.
PY - 2022
Y1 - 2022
N2 - GPIHBP1, an endothelial cell (EC) protein, captures lipoprotein lipase (LPL) within the interstitial spaces (where it is secreted by myocytes and adipocytes) and transports it across ECs to its site of action in the capillary lumen. GPIHBP1's 3-fingered LU domain is required for LPL binding, but the function of its acidic domain (AD) has remained unclear. We created mutant mice lacking the AD and found severe hypertriglyceridemia. As expected, the mutant GPIHBP1 retained the capacity to bind LPL. Unexpectedly, however, most of the GPIHBP1 and LPL in the mutant mice was located on the abluminal surface of ECs (explaining the hypertriglyceridemia). The GPIHBP1-bound LPL was trapped on the abluminal surface of ECs by electrostatic interactions between the large basic patch on the surface of LPL and negatively charged heparan sulfate proteoglycans (HSPGs) on the surface of ECs. GPIHBP1 trafficking across ECs in the mutant mice was normalized by disrupting LPL-HSPG electrostatic interactions with either heparin or an AD peptide. Thus, GPIHBP1's AD plays a crucial function in plasma triglyceride metabolism; it sheathes LPL's basic patch on the abluminal surface of ECs, thereby preventing LPL-HSPG interactions and freeing GPIHBP1-LPL complexes to move across ECs to the capillary lumen.
AB - GPIHBP1, an endothelial cell (EC) protein, captures lipoprotein lipase (LPL) within the interstitial spaces (where it is secreted by myocytes and adipocytes) and transports it across ECs to its site of action in the capillary lumen. GPIHBP1's 3-fingered LU domain is required for LPL binding, but the function of its acidic domain (AD) has remained unclear. We created mutant mice lacking the AD and found severe hypertriglyceridemia. As expected, the mutant GPIHBP1 retained the capacity to bind LPL. Unexpectedly, however, most of the GPIHBP1 and LPL in the mutant mice was located on the abluminal surface of ECs (explaining the hypertriglyceridemia). The GPIHBP1-bound LPL was trapped on the abluminal surface of ECs by electrostatic interactions between the large basic patch on the surface of LPL and negatively charged heparan sulfate proteoglycans (HSPGs) on the surface of ECs. GPIHBP1 trafficking across ECs in the mutant mice was normalized by disrupting LPL-HSPG electrostatic interactions with either heparin or an AD peptide. Thus, GPIHBP1's AD plays a crucial function in plasma triglyceride metabolism; it sheathes LPL's basic patch on the abluminal surface of ECs, thereby preventing LPL-HSPG interactions and freeing GPIHBP1-LPL complexes to move across ECs to the capillary lumen.
U2 - 10.1172/JCI157500
DO - 10.1172/JCI157500
M3 - Journal article
C2 - 35229724
AN - SCOPUS:85125560699
VL - 132
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
SN - 0021-9738
IS - 5
M1 - e157500
ER -
ID: 300450482